Arpana Agrawal, PhD, is an Associate Professor of Psychiatry at Washington University School of Medicine. She received her PhD in Human Genetics (Quantitative) from Virginia Commonwealth University.
Her research focuses on the role of genetic and genomic influences on substance use and misuse, in particular alcohol, tobacco and cannabis. She uses a variety of latent and measured genetic approaches to explore the genetic basis of comorbidities across substances and between substances and other forms of psychopathology (e.g. cannabis and suicide). A majority of her NIDA-funded research focuses on understanding the role of genomic influences on cannabis involvement and its relationship with other mental illness. She is also a co-investigator on several projects focused on substance involvement (e.g. Collaborative Study of the Genetics of Alcoholism) as well as studies incorporating genomics as a key aspect of their research paradigm. She has also served on the addiction component of PhenX, which aims to identify substance-related measures that can be readily harmonized across large-scale projects.
Dr. Agrawal co-chairs the Substance Use Disorder (SUD) group of the Psychiatric Genomics Consortium (PGC).